Goldman Sachs Group Inc. Raises Position in United States Antimony Co. $UAMY

Key Points

• Goldman Sachs Group Inc. increased its stake in United States Antimony Co. ($UAMY) by 36.3%, acquiring a total of 359,692 shares, valued at approximately $791,000.
• Several hedge funds have also invested in United States Antimony, with a total of 9.49% of the stock now owned by institutional investors.
• Brokerage firms have mostly issued a 'buy' rating for UAMY, with an average price target set at $3.38.

Goldman Sachs Group Inc. lifted its stake in shares of United States Antimony Co. (NYSE:UAMY - Free Report) by 36.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 359,692 shares of the company's stock after acquiring an additional 95,811 shares during the quarter. Goldman Sachs Group Inc. owned 0.30% of United States Antimony worth $791,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of UAMY. Two Sigma Investments LP acquired a new position in United States Antimony during the 4th quarter worth $565,000. Two Sigma Advisers LP acquired a new position in shares of United States Antimony during the fourth quarter worth about $407,000. OMERS ADMINISTRATION Corp purchased a new stake in shares of United States Antimony during the first quarter worth approximately $436,000. CW Advisors LLC acquired a new stake in United States Antimony in the first quarter valued at approximately $352,000. Finally, Russell Investments Group Ltd. purchased a new position in United States Antimony in the first quarter worth approximately $271,000. 9.49% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have commented on UAMY. HC Wainwright reissued a "buy" rating and issued a $4.50 price objective on shares of United States Antimony in a research report on Wednesday, August 13th. D. Boral Capital restated a "buy" rating and issued a $5.00 price target on shares of United States Antimony in a research note on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and four have issued a Buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $3.38.

United States Antimony Stock Performance

Shares of UAMY opened at $7.30 on Wednesday. The stock has a market capitalization of $907.59 million, a P/E ratio of -182.50 and a beta of 0.05. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.84 and a current ratio of 6.24. United States Antimony Co. has a 1 year low of $0.49 and a 1 year high of $8.17. The company's fifty day moving average is $4.31 and its two-hundred day moving average is $3.20.

United States Antimony Profile

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.

Want to see what other hedge funds are holding UAMY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for United States Antimony Co. (NYSE:UAMY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.